Arterial Elasticity: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
NCT ID: NCT01776151
Last Updated: 2023-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
337 participants
OBSERVATIONAL
2009-04-15
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
NCT01797367
Early ART to Limit Infection and Establishment of Reservoir
NCT02859558
Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
NCT01515813
Strategic Timing of Antiretroviral Treatment
NCT00867048
The "START" (a Streamlined ART Initiation Strategy) Study
NCT01810289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jason V Baker, MD
Role: STUDY_CHAIR
University of Minnesota
Daniel Duprez, MD, PhD
Role: STUDY_CHAIR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Henry Ford Health System
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Baker JV, Engen NW, Huppler Hullsiek K, Stephan C, Jain MK, Munderi P, Pett S, Duprez D; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group. Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015 Apr;16 Suppl 1(0 1):109-18. doi: 10.1111/hiv.12239.
Related Links
Access external resources that provide additional context or updates about the study.
INSIGHT network website, including information on the START Arterial Elasticity Substudy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0603M83587-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.